Granulocyte Transfusion: Current Status

Seminars in Hematology

Volumn 44, Issue 1, 2007, Pages 15-23

  Price, Thomas H ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR;

ALLOIMMUNIZATION; ARTICLE; BLOOD DONOR; CHILL; CLINICAL STUDY; CLINICAL TRIAL; FEVER; GRANULOCYTE; GRANULOCYTE FUNCTION; GRANULOCYTE TRANSFUSION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFECTION COMPLICATION; LUNG COMPLICATION; NEUTROPENIA; NEUTROPHIL COUNT; NEWBORN SEPSIS; PRIORITY JOURNAL; RECIPIENT; THERAPY EFFECT;

CASE-CONTROL STUDIES; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTES; HUMANS; LEUKAPHERESIS; LEUKOCYTE TRANSFUSION; TREATMENT OUTCOME;

EID: 33845727496     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminhematol.2006.09.015     Document Type: Article

References (75)

1. Pizzo P.A. Management of fever in patients with cancer and treatment-induced neutropenia. N Engl J Med 328 (1993) 1323-1332
2. Hughes W.T., Armstrong D., Bodey G.P., Brown A.R., Edwards J.E., Feld R., et al. 1997 Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Clin Infect Dis 25 (1997) 551-573
3. Grow W.B., Moreb J.S., Roque D., Manion K., Leather H., Reddy V., et al. Late onset of invasive aspergillus infection in bone marrow transplant patients at a university hospital. Bone Marrow Transplant 29 (2002) 15-19
4. Marr K.A., Carter R.A., and Crippa F. Epidemiology and outcome of mould infections in hematopoietic stem cell tranplant patients. Clin Infect Dis 34 (2002) 909-917
5. Marr K.A., Boeckh M., and Carter R.A. Combination antifungal therapy for invasive aspergillosis. Clin Infect Dis 39 (2004) 797-802
6. Wingard J.R. Fungal infections after bone marrow transplant. Biol Blood Marrow Transplant 5 (1999) 55-68
7. Boutati E.I., and Anaissie E.J. Fusarium, a significant emerging pathogen in patients with hematologic malignancy: Ten years' experience at a cancer center and implications for management. Blood 90 (1997) 999-1008
8. Imhof A., Balajee A., and Fredricks D.N. Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole. Clin Infect Dis 39 (2004) 743-746
9. Herbrecht R., Denning D.W., Patterson T.F., Bennett J.E., Greene R.E., Oestmann J.-W., et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 347 (2002) 408-415
10. Dutcher J.P., Schiffer C.A., Johnston G.S., Papenburg D., Daly P.A., Aisner J., et al. Alloimmunization prevents the migration of transfused indium-111-labeled granulocytes to sites of infection. Blood 62 (1983) 354-360
11. Dutcher J.P., Riggs J.R., Fox J.J., Johnston G.S., Norris D., Wiernik P.H., et al. Effect of histocompatibility factors on pulmonary retention of indium-111-labeled granulocytes. Am J Hematol 33 (1990) 238-243
12. Stroncek D.F., Leonard K., and Eiber G. Alloimmunization after granulocyte transfusions. Transfusion 36 (1996) 1009-1015
13. McCullough J., Clay M., and Hurd D. Effect of leukocyte antibodies and HLA matching on the intravascular recovery, survival, and tissue localization of 111-indium granulocytes. Blood 67 (1986) 522-528
14. Hinckley M.E., and Huestis D.W. Premedication for optimal granulocyte collection. Plasma Ther 2 (1981) 149-152
15. Winton E.F., and Vogler W.R. Development of a practical oral dexamethasone premedication schedule leading to improved granulocyte yields with the continuous-flow centrifugal blood cell separator. Blood 52 (1978) 249-253
16. Price T.H., and Dale D.C. Blood kinetics and in vivo chemotaxis of transfused neutrophils: Effect of collection method, donor corticosteroid treatment, and short-term storage. Blood 54 (1979) 977-986
17. Glasser L., Huestis D.W., and Jones J.F. Functional capabilities of steroid-recruited neutrophils harvested for clinical transfusion. N Eng J Med 297 (1977) 1033-1036
18. Price T.H. Neutrophil transfusion. In vivo function of neutrophils collected using cell separators. Transfusion 23 (1983) 504-507
19. Dale D.C., Liles W.C., and Summer W.R. Granulocyte colony-stimulating factor: Role and relationships in infectious diseases. J Infect Dis 172 (1995) 1061-1075
20. McCullough J., Weiblen B.J., and Fine D. Effects of storage of granulocytes on their fate in vivo. Transfusion 23 (1983) 20-24
21. Glasser L., Lane T.A., and McCullough J. Panel VII: Neutrophil concentrates-Functional considerations, storage, and quality control. J Clin Apheresis 1 (1983) 179-184
22. McCullough J., Weiblen B.J., and Peterson P.K. Effects of temperature on granulocyte preservation. Blood 52 (1978) 301-310
23. Anderson K.C., and Weinstein H.J. Transfusion-associated graft-versus-host disease. N Engl J Med 323 (1990) 315-321
24. Schwarzenberg L., Mathé G., de Grouchy J., deNava C., deVries M.J., Amiel J.L., et al. White blood cell transfusions. Isr J Med Sci 1 (1965) 925-956
25. Morse E.E., Freireich E.J., and Carbone P.P. The transfusion of leukocytes from donors with chronic myelocytic leukemia to patients with leukopenia. Transfusion 6 (1966) 183-192
26. Lowenthal R.M., Grossman L., Goldman J.M., Storring R.A., Buskare N.A., Park D.S., et al. Granulocyte transfusions in treatment of infections in patients with acute leukaemia and aplastic anaemia. Lancet 1 (1975) 353-358
27. Strauss R.G. Granulocyte (neutrophil) transfusion. In: McLeod B.C., Price T.H., and Weinstein R. (Eds). Apheresis: Principles and Practice. (ed 2) (2003), AABB Press, Bethesda, MD 237-252/6
28. Graw R.G., Herzig G.H., and Perry S. Normal granulocyte transfusion therapy: Treatment of septicemia due to gram-negative bacteria. N Engl J Med 287 (1972) 367-371
29. Higby D.J., Yates J.W., and Henderson E.S. Filtration leukapheresis for granulocyte transfusion therapy: Clinical and laboratory studies. N Engl J Med 292 (1975) 761-766
30. Fortuny I.E., Bloomfield C.D., and Hadlock D.C. Granulocyte transfusion: A controlled study in patients with acute nonlymphocytic leukemia. Transfusion 15 (1975) 548-557
31. Vogler W.R., and Winton E.F. A controlled study of the efficacy of granulocyte transfusions in patients with neutropenia. Am J Med 63 (1977) 548-555
32. Alavi J.B., Root R.K., Djerassi I., Evans A.E., Gluckman S.J., MacGregor R.R., et al. A randomized clinical trial of granulocyte transfusions for infection in acute leukemia. N Engl J Med 296 (1977) 706-711
33. Herzig R.H., Herzig G.P., and Graw R.G. Successful granulocyte transfusion therapy for gram-negative septicemia: A prospectively randomized controlled study. N Engl J Med 296 (1977) 701-705
34. Winston D.J., Ho W.G., and Gale R.P. Therapeutic granulocyte transfusions for documented infections: A controlled trial in ninety-five infectious granulocytopenic episodes. Ann Intern Med 97 (1982) 509-515
35. Strauss R.G. Therapeutic granulocyte transfusions in 1993. Blood 81 (1993) 1675-1678
36. Vamvakas E.C., and Pineda A.A. Meta-analysis of clinical studies of the efficacy of granulocyte transfusions in the treatment of bacterial sepsis. J Clin Apheresis 11 (1996) 1-9
37. Bhatia S., McCullough J., and Perry E.H. Granulocyte transfusions: Efficacy in treating fungal infections in neutropenic patients following bone marrow transplantation. Transfusion 34 (1994) 226-232
38. Strauss R.G. Granulocyte transfusions. In: Rossi E.C., Simon T.L., Moss G.S., et al. (Eds). Principles of Transfusion Medicine. (ed 2) (1996), Williams & Wilkins, Baltimore, MD 321-328
39. Strauss R.G., Connett J.E., Gale R., Bloomfield C.D., Herzig G.P., McCullough J., et al. A controlled trial of prophylactic granulocyte transfusions during initial induction chemotherapy for acute myelogenous leukemia. N Engl J Med 305 (1981) 597-603
40. Rosenshein M.S., Farewell V.T., and Price T.H. The cost effectiveness of therapeutic and prophylactic leukocyte transfusion. N Engl J Med 302 (1980) 1058-1062
41. Christensen R.D., Anstall H.B., and Rothstein G. Deficiencies in the neutrophil system of newborn infants, and the use of leukocyte transfusions in the treatment of neonatal sepsis. J Clin Apheresis 1 (1982) 33-41
42. Buescher E.S., and Gallin J.I. Leukocyte tranfusions in chronic granulomatous disease: Persistence of transfused leukocytes in sputum. N Engl J Med 307 (1982) 800-803
43. Bowen T.J., Ochs H.D., Altman L.C., Price T.H., Van Epps D.E., Brautigan D.L., et al. Severe recurrent bacterial infections associated with defective adherence and chemotaxis in two patients with neutrophils deficient in a cell-associated glycoprotein. J Pediatr 101 (1982) 932-940
44. Wright D.G., Robichaud K.J., and Pizzo P.A. Lethal pulmonary reactions associated with the combined use of amphotericin B and leukocyte transfusions. N Engl J Med 304 (1981) 1185-1189
45. Dutcher J.P., Kendall J., and Norris D. Granulocyte transfusion therapy and amphotericin B: Adverse reactions?. Am J Hematol 31 (1989) 102-108
46. Dana B.W., Durie B.G., and White R.F. Concomitant administration of granulocyte transfusions and amphotericin B in neutropenic patients: absence of significant pulmonary toxicity. Blood 57 (1981) 90-94
47. Pegels J.G., Bruynes E.C.E., and Engelriet C.P. Serological studies in patients on platelet- and granulocyte-substitution therapy. Br J Haematol 52 (1982) 59-68
48. Arnold R., Goldmann S.F., and Pflieger H. Lymphocytotoxic antibodies in patients receiving granulocyte transfusion. Vox Sang 38 (1980) 250-258
49. Price T.H., Bowden R.A., Boeckh M., Bux J., Nelson K., Liles W.C., et al. Phase I/II trial of neutrophil transfusions from donors stimulated with G-CSF and dexamethasone for treatment of patients with infections in hematopoietic stem cell transplantation. Blood 95 (2000) 3302-3309
50. Adkins D.R., Goodnough L.T., and Shenoy S. Effect of leukocyte incompatibility on neutrophil increment after transfusion of granulocyte colony-stimulating factor-mobilized prophylactic granulocyte transfusions and on clinical outcomes after stem cell transplantation. Blood 95 (2000) 3605-3612
51. Appelbaum F.R., Bowles C.A., and Makuch R.W. Granulocyte transfusion therapy of experimental Pseudomonas septicemia: Study of cell dose and collection technique. Blood 52 (1978) 323-331
52. Epstein R.B., and Chow H.S. An analysis of quantitative relationships of granulocyte transfusion therapy in canines. Transfusion 21 (1981) 360-362
53. Chatta G.S., Price T.H., and Allen R.C. Effects of in vivo recombinant methionyl human granulocyte colony-stimulating factor on the neutrophil response and peripheral blood colony-forming cells in healthy young and elderly adult volunteers. Blood 84 (1994) 2923-2929
54. Price T.H., Chatta G.S., and Dale D.C. Effect of recombinant granulocyte colony-stimulating factor on neutrophil kinetics in normal young and elderly humans. Blood 88 (1996) 335-340
55. Liles W.C., Huang J.E., and Llewellyn C. A comparative trial of granulocyte-colony-stimulating factor and dexamethasone, separately and in combination, for the mobilization of neutrophils in the peripheral blood of normal volunteers. Transfusion 37 (1997) 182-187
56. Stroncek D.F., Clay M.E., and Petzoldt M.L. Treatment of normal individuals with granulocyte-colony-stimulating factor: Donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells. Transfusion 36 (1996) 601-610
57. Anderlini P., Przepiorka D., Seong D., Miller P., Sundberg J., Lichtiger B., et al. Clinical toxicity and laboratory effects of granulocyte-colony-stimulating factor (filgrastim) mobilization and blood stem cell apheresis from normal donors, and analysis of charges for the procedures. Transfusion 36 (1996) 590-595
58. Liles W.C., and Klebanoff S.J. Regulation of apoptosis in neutrophils: Fast track to death?. J Immunol 155 (1995) 3289-3291
59. Hester J.P., Dignani M.C., and Anaissie E.J. Collection and transfusion of granulocyte concentrates from donors primed with granulocyte stimulating factor and response of myelosuppressed patients with established infection. J Clin Apheresis 10 (1995) 188-193
60. Adkins D., Spitzer G., and Johnston M. Transfusions of granulocyte-colony-stimulating factor-mobilized granulocyte components to allogeneic transplant recipients: Analysis of kinetics and factors determining posttransfusion neutrophil and platelet counts. Transfusion 37 (1997) 737-748
61. Dale D.C., Liles W.C., and Llewellyn C. Neutrophil transfusions: Kinetics and functions of neutrophils mobilized with granulocyte colony-stimulating factor (G-CSF) and dexamethasone. Transfusion 38 (1998) 713-721
62. Adkins D., Goodgold H., and Hendershott L. Indium-labeled white blood cells apheresed from donors receiving G-CSF localize to sites of inflammation when infused into allogeneic bone marrow transplant recipients. Bone Marrow Transplant 19 (1997) 809-812
63. Grigg A., Vecchi L., and Bardy P. G-CSF-stimulated donor granulocyte collections for prophylaxis and therapy of neutropenic sepsis. Aust N Z J Med 26 (1996) 813-818
64. Kerr J.P., Liakopolou E., Brown J., Cornish J.M., Fleming D.E., Massey E., et al. The use of stimulated granulocyte transfusions to prevent recurrence of past severe infections after allogeneic stem cell transplantation. Br J Haematol 123 (2003) 114-118
65. Peters C., Minkov M., Matthes-Martin S., Potshger U., Witt V., Mann G., et al. Leucocyte transfusions from rhG-CSF or prednisolone stimulated donors for treatment of severe infections in immunocompromised neutropenic patients. Br J Haemotol 106 (1999) 689-696
66. Rutella S., Pierelli L., Piccirillo N., Sica S., Serafini R., Chiusolo P., et al. Efficacy of granulocyte transfusions for neutropenia-related infections: retrospective analysis of predictive factors. Cytotherapy 5 (2003) 19-30
67. Nichols W.G., Strauss R.G., Ambruso D., King K., Rolston K., Sinner P., et al. G-CSF-stimulated granulocyte transfusions from unrelated community donors for severe infections during neutropenia: A phase II multicenter trial of feasibility and efficacy. Blood 102 (2003) 978a (abstr)
68. Lee J.J., Song H.C., and Chung I.J. Clinical efficacy and prediction of response to granulocyte transfusion therapy for patients with neutropenia-related infections. Haematologica 89 (2004) 632-633
69. Grigull L., Pulver N., Goudeva L., Sykors K., Linderkamp C., Beilken A., et al. G-CSF mobilised granulocyte transfusions in 32 paediatric patients with neutropenic sepsis. Support Care Cancer 14 (2006) 910-916
70. Illerhaus G., Wirth K., Dwenger A., Waller C.F., Garbe A., Brass V., et al. Treatment and prophylaxis of severe infections in neutropenic patients by granulocyte transfusions. Ann Hematol 81 (2002) 273-281
71. Mousset S., Hermann S., Klein S., Bialleck H., Duchscherer M., Bomke B., et al. Prophylactic and interventional granulocyte transfusions in patients with haematological malignancies and life-threatening infections during neutropenia. Ann Hematol 84 (2005) 734-741
72. Oza A., Hallemeier C., Goonough L., Khoury H., Shenoy S., Devine S., et al. Granulocyte-colony-stimulating factor-mobilized prophylactic granulocye transfusions given after allogeneic peripheral blood progenitor cell transplantation result in a modest reduction of febrile days and intravenous antibiotic usage. Transfusion 46 (2006) 14-23
73. Hubel K., Carter R.A., Liles W.C., Dale D.C., Price T.H., Bowden R.A., et al. Granulocyte transfusion therapy for infections in candidates and recipients of HPC transplantation: A comparitive analysis of feasibility and outcome for community donors versus related donors. Transfusion 42 (2002) 1414-1421
74. Safdar A., Hanna H.A., Boktour M., Kontoyiannis D.P., Hachem R., Lichtiger B., et al. Impact of high-dose granulocyte transfusions in patients with cancer with candidemia. Cancer 101 (2004) 2859-2865
75. Bensinger W.I., Price T.H., Dale D.C., Applebaum F.R., Clift R., Lilleby K., et al. The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood 81 (1993) 1883-1888